# Effect of Intermittent Oro-esophageal Tube vs Nasogastric Tube in Tracheostomized Patients With Intracerebral Hemorrhage

Study · id `cardio:ct-nct06203561` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06203561](<https://clinicaltrials.gov/study/NCT06203561>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT06203561

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 118 participants.

## Technical summary

Registry record NCT06203561. Randomized; double masking; primary purpose treatment. Start 2023-01-17 (actual); primary completion 2023-06-05 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 118 participants (enrolled count; ClinicalTrials.gov record NCT06203561, source copy `cardio:ctgov-nct06203561-2024-03-08`, retrieved 2026-10-31)
- Started: 2023-01-17 (actual) (ClinicalTrials.gov record NCT06203561, source copy `cardio:ctgov-nct06203561-2024-03-08`, retrieved 2026-10-31)
- Primary completion: 2023-06-05 (actual) (ClinicalTrials.gov record NCT06203561, source copy `cardio:ctgov-nct06203561-2024-03-08`, retrieved 2026-10-31)
- Completion: 2023-06-12 (actual) (ClinicalTrials.gov record NCT06203561, source copy `cardio:ctgov-nct06203561-2024-03-08`, retrieved 2026-10-31)
- Countries: China (ClinicalTrials.gov record NCT06203561, source copy `cardio:ctgov-nct06203561-2024-03-08`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "TERMINATED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06203561-2024-03-08`, retrieved 2026-10-31)

## The registry's words

- Brief title: Effect of Intermittent Oro-esophageal Tube vs Nasogastric Tube in Tracheostomized Patients With Intracerebral Hemorrhage
- Condition: Intracerebral Hemorrhage
- Intervention (Behavioral): Basic treatment
- Intervention (Behavioral): comprehensive rehabilitation therapy
- Intervention (Device): Intermittent Oro-esophageal Tube Feeding
- Intervention (Device): Nasogastric Tube Feeding
- Lead sponsor: Zeng Changhao
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Bleeding in the brain (intracerebral hemorrhage) (`cardio:intracerebral-hemorrhage`)

## Provenance

Content hash: 94691ceff2d89b2ac982945601565b524f842d9598da2713dc999d631ab5a59f
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
